reflux esophagitis
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) People aged 20 or older who have provided written consent to participate in this study 2) RE patients under treatment with acid suppressants
Exclusion criteria
Exclusion criteria: 1) Patients with warning signs such as vomiting, gastrointestinal bleeding (including findings of hematemesis, melena, and anemia), or sudden weight loss 2) Patients with a confirmed or suspected malignant lesion 3) Patients with a history of gastrointestinal resection or vagotomy 4) Patients with irritable bowel syndrome 5) Hypergastrinemic patients with renal failure, ZE syndrome, etc 6) Patients complicated by serious hepatic, renal, cardiac, or other diseases 7) Patients on NSAIDs and low-dose aspirin 8) Patients with pernicious anemia 9) Other patients judged by their attending physicians to be inappropriate for this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To investigate the association between total score evaluated by F-scale and fasting blood gastrin level | — |
Countries
Japan
Contacts
Kawasaki Medical School Internal Medicine Division of Gastroenterology